Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,693 | 1,029 | 99.8% |
| Education | $36.24 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,248 | 209 | $0 (2024) |
| Amgen Inc. | $1,713 | 117 | $0 (2024) |
| ABBVIE INC. | $1,599 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,507 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,455 | 92 | $0 (2024) |
| PFIZER INC. | $935.70 | 74 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $604.88 | 42 | $0 (2023) |
| Allergan, Inc. | $589.42 | 68 | $0 (2020) |
| Shire North American Group Inc | $322.09 | 24 | $0 (2019) |
| Merck Sharp & Dohme LLC | $297.11 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,019 | 118 | ABBVIE INC. ($393.42) |
| 2023 | $2,458 | 151 | Novo Nordisk Inc ($419.15) |
| 2022 | $1,893 | 125 | ABBVIE INC. ($403.46) |
| 2021 | $2,436 | 162 | AbbVie Inc. ($380.40) |
| 2020 | $1,574 | 118 | AstraZeneca Pharmaceuticals LP ($288.98) |
| 2019 | $1,149 | 85 | Novo Nordisk Inc ($192.60) |
| 2018 | $1,756 | 142 | Amgen Inc. ($245.34) |
| 2017 | $1,444 | 130 | GlaxoSmithKline, LLC. ($250.28) |
All Payment Transactions
1,031 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Endocrinology | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Obesity | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,082 | 1,711 | $273,211 | $64,302 |
| 2022 | 19 | 1,008 | 1,584 | $297,083 | $66,296 |
| 2021 | 19 | 1,152 | 1,888 | $280,673 | $65,883 |
| 2020 | 17 | 1,114 | 1,818 | $346,497 | $70,299 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 393 | $121,546 | $30,538 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 315 | $66,888 | $16,884 | 25.2% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 17 | 19 | $12,195 | $2,656 | 21.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 42 | $5,029 | $1,888 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $8,226 | $1,804 | 21.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 165 | 234 | $11,228 | $1,760 | 15.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $5,915 | $1,431 | 24.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 49 | 60 | $8,182 | $1,235 | 15.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $4,032 | $1,151 | 28.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 32 | $4,706 | $1,114 | 23.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 26 | $5,850 | $1,078 | 18.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 102 | $10,051 | $963.48 | 9.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $1,883 | $540.36 | 28.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 137 | 184 | $2,560 | $398.75 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 36 | $2,574 | $314.70 | 12.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 41 | 45 | $480.15 | $274.95 | 57.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 25 | 28 | $1,308 | $233.42 | 17.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 29 | $508.95 | $28.59 | 5.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 25 | 92 | $48.80 | $8.49 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 356 | $110,388 | $27,010 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 439 | $92,690 | $22,607 | 24.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 24 | 31 | $19,897 | $4,355 | 21.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $5,608 | $1,849 | 33.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 33 | 43 | $9,675 | $1,354 | 14.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $5,470 | $1,335 | 24.4% |
About Dr. John Major, MD
Dr. John Major, MD is a Family Medicine healthcare provider based in Hermitage, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487635777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Major, MD has received a total of $14,730 in payments from pharmaceutical and medical device companies, with $2,019 received in 2024. These payments were reported across 1,031 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($14,693).
As a Medicare-enrolled provider, Major has provided services to 4,356 Medicare beneficiaries, totaling 7,001 services with total Medicare billing of $266,780. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hermitage, TN
- Active Since 11/14/2005
- Last Updated 05/31/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487635777
Products in Payments
- Ozempic (Drug) $1,046
- VRAYLAR (Drug) $1,010
- FARXIGA (Drug) $860.85
- TRELEGY ELLIPTA (Drug) $858.13
- Otezla (Drug) $838.14
- Aimovig (Biological) $532.47
- XARELTO (Drug) $506.19
- NURTEC ODT (Drug) $462.46
- QULIPTA (Drug) $423.60
- Rybelsus (Drug) $361.28
- UBRELVY (Drug) $309.35
- BREO (Drug) $245.73
- Prolia (Biological) $240.94
- Victoza (Drug) $213.75
- VYVANSE (Drug) $187.91
- Wegovy (Drug) $185.98
- SYMBICORT (Drug) $184.73
- ZENPEP (Drug) $177.43
- XIFAXAN (Drug) $176.11
- ANORO (Drug) $175.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hermitage
Richard Pak, Md, MD
Family Medicine — Payments: $20,563
Dr. Charles D'auria, D.o, D.O
Family Medicine — Payments: $19,203
Dr. Heather Porter, D.o, D.O
Family Medicine — Payments: $17,422
Robert Gaston, Md, MD
Family Medicine — Payments: $16,063
Mindi Hamby, Md, MD
Family Medicine — Payments: $15,709
Richard Stigliano
Family Medicine — Payments: $14,985